Fifth Third Bancorp’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4K Sell
118
-7
-6% -$796 ﹤0.01% 1919
2025
Q1
$13.1K Buy
125
+38
+44% +$4K ﹤0.01% 1912
2024
Q4
$9.32K Sell
87
-27
-24% -$2.89K ﹤0.01% 1997
2024
Q3
$11.4K Buy
114
+5
+5% +$500 ﹤0.01% 1950
2024
Q2
$9.18K Buy
109
+11
+11% +$927 ﹤0.01% 1956
2024
Q1
$7.16K Hold
98
﹤0.01% 1961
2023
Q4
$7K Sell
98
-55
-36% -$3.93K ﹤0.01% 2076
2023
Q3
$9.17K Buy
153
+25
+20% +$1.5K ﹤0.01% 1985
2023
Q2
$9.23K Buy
128
+3
+2% +$216 ﹤0.01% 2003
2023
Q1
$9.2K Buy
125
+52
+71% +$3.83K ﹤0.01% 2133
2022
Q4
$4.88K Buy
73
+7
+11% +$468 ﹤0.01% 2216
2022
Q3
$4K Sell
66
-43
-39% -$2.61K ﹤0.01% 2244
2022
Q2
$6K Buy
109
+29
+36% +$1.6K ﹤0.01% 2171
2022
Q1
$6K Sell
80
-7,792
-99% -$584K ﹤0.01% 2245
2021
Q4
$759K Buy
7,872
+7,733
+5,563% +$746K ﹤0.01% 624
2021
Q3
$12K Sell
139
-238
-63% -$20.5K ﹤0.01% 1946
2021
Q2
$31K Sell
377
-89
-19% -$7.32K ﹤0.01% 1637
2021
Q1
$44K Sell
466
-424
-48% -$40K ﹤0.01% 1486
2020
Q4
$55K Sell
890
-4,616
-84% -$285K ﹤0.01% 1348
2020
Q3
$327K Sell
5,506
-1,978
-26% -$117K ﹤0.01% 729
2020
Q2
$522K Buy
7,484
+339
+5% +$23.6K ﹤0.01% 622
2020
Q1
$324K Buy
7,145
+643
+10% +$29.2K ﹤0.01% 693
2019
Q4
$423K Sell
6,502
-239
-4% -$15.5K ﹤0.01% 690
2019
Q3
$419K Buy
6,741
+930
+16% +$57.8K ﹤0.01% 684
2019
Q2
$414K Buy
5,811
+443
+8% +$31.6K ﹤0.01% 680
2019
Q1
$421K Buy
5,368
+254
+5% +$19.9K ﹤0.01% 656
2018
Q4
$433K Buy
5,114
+1,262
+33% +$107K ﹤0.01% 651
2018
Q3
$660K Sell
3,852
-1,020
-21% -$175K ﹤0.01% 601
2018
Q2
$630K Sell
4,872
-1,213
-20% -$157K ﹤0.01% 628
2018
Q1
$627K Sell
6,085
-1,629
-21% -$168K ﹤0.01% 610
2017
Q4
$659K Buy
7,714
+440
+6% +$37.6K ﹤0.01% 599
2017
Q3
$618K Sell
7,274
-896
-11% -$76.1K ﹤0.01% 603
2017
Q2
$619K Buy
8,170
+107
+1% +$8.11K ﹤0.01% 629
2017
Q1
$532K Sell
8,063
-680
-8% -$44.9K ﹤0.01% 688
2016
Q4
$554K Sell
8,743
-56
-0.6% -$3.55K ﹤0.01% 691
2016
Q3
$560K Sell
8,799
-304
-3% -$19.3K ﹤0.01% 700
2016
Q2
$677K Sell
9,103
-1,478
-14% -$110K 0.01% 636
2016
Q1
$707K Sell
10,581
-12
-0.1% -$802 0.01% 623
2015
Q4
$716K Sell
10,593
-715
-6% -$48.3K 0.01% 629
2015
Q3
$604K Buy
11,308
+1,071
+10% +$57.2K 0.01% 687
2015
Q2
$644K Sell
10,237
-4,386
-30% -$276K 0.01% 681
2015
Q1
$703K Buy
14,623
+1,551
+12% +$74.6K 0.01% 666
2014
Q4
$434K Buy
13,072
+3,855
+42% +$128K ﹤0.01% 758
2014
Q3
$270K Sell
9,217
-484
-5% -$14.2K ﹤0.01% 886
2014
Q2
$377K Buy
9,701
+6,607
+214% +$257K ﹤0.01% 818
2014
Q1
$130K Buy
+3,094
New +$130K ﹤0.01% 1091